Eli Marsden
Founding Editor
Editorial role · not a licensed clinician
Eli Marsden is the founding editor of Weight Loss Rankings. He spent his early career in healthcare investment banking and the past 10+ years building pharmaceutical companies — leading drug development programs that resulted in FDA approvals and named inventor on multiple patents for new therapeutics.
Eli is bilingual (English and Spanish) and personally edits both the English and the Spanish corpus on Weight Loss Rankings. The /es/research articles are first-party translations and adaptations, not machine-translated copies of the English versions — clinical terminology, dosing units, and regulatory references are reviewed in both languages by the same editor who shipped the English original.
Eli is not a licensed clinician. Every clinical claim on Weight Loss Rankings is sourced to FDA prescribing information, PubMed-indexed primary research, or named regulatory filings. All health content is editorially reviewed by Eli with the support of structured verification workflows; we are actively seeking a credentialed medical reviewer (MD, PharmD, NP) to join the editorial team.
Weight Loss Rankings is reader-supported via affiliate commissions on a subset of provider links. Editorial scores and rankings are produced independently of the affiliate relationships and are not for sale. The full disclosure policy is published at /disclosure and the six-dimension scoring methodology is at /methodology.
When Eli is not editing, he is still in the pharma industry — which is both a meaningful experience signal for understanding how the GLP-1 telehealth market actually works and a potential conflict of interest readers should be aware of. Any direct conflicts on a specific provider are disclosed inline on that provider's review page.
Subject expertise
- GLP-1 receptor agonists
- Semaglutide
- Tirzepatide
- Orforglipron
- Pharmaceutical drug development
- FDA drug approval process
- Compounded medications regulation
- Telehealth weight management
- Healthcare investment banking
- Biotechnology
- Drug patent prosecution
How Eli Marsden reviews content for Weight Loss Rankings
Every research article and provider review goes through a structured verification workflow before publication. Clinical claims are sourced to FDA prescribing information, PubMed-indexed primary research, or named regulatory filings. Provider data is verified against the live provider page. Pricing is re-verified on a recurring cadence.
Read the full editorial process at /editorial-policy, the six-dimension scoring rubric at /methodology, the corrections policy at /corrections, and our affiliate disclosure at /disclosure.